The recruitment of African-Americans to cancer prevention and control studies

Preventive Medicine

Volumn 25, Issue 5, 1996, Pages 547-553

  Paskett, Electra D ^a   DeGraffinreid, Cecilia ^a   Tatum, Cathy M ^a   Margitić, Susan E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; cancer prevention; cancer screening; recruitment

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CLINICAL TRIAL; COLON POLYP; DOUBLE BLIND PROCEDURE; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGRO; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0030249147     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1996.0088     Document Type: Article

References (26)

1. 1. Baquet CR, Clayton LA, Robinson RG. Cancer prevention and control. In: Minorities and cancer. Berlin/New York: Springer-Verlag, 1986.
2. 2. American Cancer Society. Cancer facts and figures for minority Americans, 1986.
3. 3. Cancer Prevention Awareness Program. National Knowledge, Attitudes, and Behavior Cancer Risk Survey, 1989. Natl. Cancer Inst., 1989.
4. 4. National Health Interview Survey. Provisional estimates from the National Health Interview Survey Supplement on Cancer Control - United States, January-March, 1987. MMWR 1988;37:417-420, 425.
5. 5. Hunter CP. Cancer control and the community oncology programs: minority participation in the National Cancer Institute Clinical Trials Network. In: Minorities and cancer. Berlin/New York: Springer-Verlag, 1986.
6. 6. Swanson GM. Overview of the barriers for trial participation among the different ethnic groups in the U.S. Proceedings of the 85th Annual Meeting of the American Association for Cancer Research, 1993;35.
7. 7. Office of Research on Women's Health. Recruitment and retention of women in clinical studies: a report of the Task Force on the Recruitment and Retention of Women in Clinical Studies. Washington: Natl. Inst. Health, 1994 Aug.
8. 8. Bateman M, Kardinal D, Lifsey D, Gralla RJ, Washington A, Scroggins T, et al. Barriers to minority recruitment: implications for chemoprevention trials. Proc Am Soc Clin Oncol 1993;12:169.
9. 9. Lacey L. Cancer prevention and early detection strategies for reaching underserved urban, low-income black women. Cancer 1993;72:1078-83.
10. 10. Sung JFC, Coates RJ, Williams JE, Liff JM, Greenberg RS, McGrady GA, et al. Cancer screening intervention among black women in inner-city Atlanta - design of a study. Public Health Rep 1992;7:381-8.
11. 11. Pickle LW, Mason TJ, Howard N, Hoover R, Fraumeni JF Jr. Atlas of U.S. cancer mortality among non-whites: 1950-1980. Bethesda (MD): Natl. Cancer Inst., 1990; DHHS Publication No. (NIH) 90-1582.
12. 12. Freedman LS, Schatzkin A. Sample size for studying intermediate endpoints within intervention trials or observational studies. Am J Epidemiol 1992;136:1148-59.
13. 13. Rothman J, Erlich RL, Teresa JG. Changing organizations and community programs. Beverly Hills (CA): Sage, 1981.
14. 14. Eng E. The Save Our Sisters Project: a social network strategy for reaching rural black women. Cancer 1993;72:1071-7.
15. 15. Demark-Wahnefried W, Catoe KE, Paskett ED, Robertson CN, Rimer BK. Characteristics of men reporting for prostate cancer screening. Urology 1993;42:269-75.
16. 16. Marcus AC, Crane LA, Kaplan CP, Reading AE, Savage E, Gunning J, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care 1992;30:216-30.
17. 17. Robinson RG, Kessler LG, Naughton DM. Cancer awareness among African-Americans: a survey assessing race, social status, and occupation. J Natl Med Assoc 1991;83:491-7.
18. 18. Hardy RE, Hargreaves MK. Cancer prognosis in black Americans: a mini-review. J Natl Med Assoc 1991;83:574-9.
19. 19. Ballard EL, Nash F, Raiford K, Harrell LE. Recruitment of black elderly for clinical research studies of dementia: the CERAD experience. Gerontologist 1993;33:561-5.
20. 20. Thomas CR Jr, Pinto HA, Roach M III, Vaughn CB. Participation in clinical trials: is it state-of-the-art treatment for African-Americans and other people of color? J Natl Med Assoc 1994;86:177-82.
21. 21. Jones JH, Bad blood: the Tuskegee syphilis experiment. New York: Free Press, 1993.
22. 22. Millon-Underwood S, Sanders E, Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection/ screening, and treatment trials among African-Americans. Cancer Nurs 1993;16:25-33.
23. 23. Millon-Underwood S, Sanders E. Factors contributing to health promotion behaviors among African-American men. Oncol Nurs Forum 1990;15:707-12.
24. 24. Eley WJ, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, et al. Racial differences in survival from breast cancer. JAMA 1994;272:947-54.
25. 25. Blumenthal DS, Sung J, Coates R, Williams J, Liff J. Mounting research addressing issues of race/ethnicity in health care. Health Serv Res 1995;30:197-205.
26. 26. McCabe MS, Varricchio CG, Padberg RM. Efforts to recruit the economically disadvantaged to national clinical trials. Semin Oncol Nurs 1994;10:123-9.